TerrAscend Corp.
USD0.65
+0.01 (+0.99%)
CEO
Ziad Ghanem
IPO Date
2017-11-17
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
OTC
Country
US
Open
$0.66
Prev. Close
$0.64
Day Low
$0.64
Day High
$0.66
52W Low
$0.26
52W High
$1.45
Market Cap
$0.24B
Volume
0.09M
| -2.3 |
| 31 Dec 2023 | FY | 43.5% | -28.7% | -28.5% | -13.7% | 0.80 | 0.50 | -5.1 |
| 31 Dec 2022 | FY | 49.8% | -126.4% | -94.5% | -31.9% | 0.77 | 0.88 | -0.9 |
| 31 Dec 2021 | FY | 55.1% | 1.3% | 1.4% | 0.4% | 0.95 | 2.61 | 363.6 |
| 31 Dec 2020 | FY | 13.3% | -78.2% | -13068.5% | -25.7% | 221.95 | 1.36 | -12.3 |
| 31 Dec 2019 | FY | -3.1% | -254.3% | -323.6% | -46.8% | 1.64 | 0.59 | -1.3 |
| 31 Dec 2018 | FY | -49.0% | -322.7% | -39.0% | -24.8% | 0.22 | 2.62 | -24.0 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -10.1% | -9.9% | 0.00 | 31.73 | -16.8 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -41.7% | -22.4% | 0.00 | 1.94 | -40.8 |
| 22.0 |
| 30 Sept 2025 | Q3 | 52.1% | -39.6% | -27.4% | -4.6% | 2.71 | 1.56 | -2.5 |
| 30 Jun 2025 | Q2 | 51.1% | -76.0% | -41.9% | -8.6% | 2.05 | 1.45 | -0.4 |
| 31 Mar 2025 | Q1 | 51.8% | -19.1% | -8.2% | -2.3% | 1.49 | 1.31 | -2.6 |
| 31 Dec 2024 | Q4 | 50.2% | -42.8% | -18.0% | -5.2% | 1.39 | 1.33 | -1.4 |
| 30 Sept 2024 | Q3 | 48.8% | -31.2% | -11.2% | -3.5% | 1.20 | 1.35 | -3.8 |
| 30 Jun 2024 | Q2 | 56.1% | -12.2% | -3.6% | -1.2% | 1.08 | 1.35 | -10.5 |
| 31 Mar 2024 | Q1 | 61.1% | -21.2% | -7.4% | -1.9% | 1.08 | 0.49 | -8.5 |
| 31 Dec 2023 | Q4 | 61.8% | -45.9% | -16.4% | -4.5% | 1.05 | 0.50 | -3.0 |